Academic Journal

PCN137 COST COMPARISON OF ADVERSE EVENTS AND TREATMENT ADMINISTRATION OF LURBINECTEDIN VERSUS INTRAVENOUS TOPOTECAN FOR RELAPSED SMALL CELL LUNG CANCER IN SPAIN AND THE UNITED KINGDOM

التفاصيل البيبلوغرافية
العنوان: PCN137 COST COMPARISON OF ADVERSE EVENTS AND TREATMENT ADMINISTRATION OF LURBINECTEDIN VERSUS INTRAVENOUS TOPOTECAN FOR RELAPSED SMALL CELL LUNG CANCER IN SPAIN AND THE UNITED KINGDOM
المؤلفون: García San Andrés, B., Ubi, S., Alvarez-Alvarez, R., Barwood, C., Olmedo-García, M.E., Foster, M.
المصدر: Value in Health ; volume 22, page S462 ; ISSN 1098-3015
بيانات النشر: Elsevier BV
سنة النشر: 2019
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.jval.2019.09.333
الاتاحة: http://dx.doi.org/10.1016/j.jval.2019.09.333
https://api.elsevier.com/content/article/PII:S1098301519327111?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1098301519327111?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/
رقم الانضمام: edsbas.23470DC0
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.jval.2019.09.333